Rheumatoid arthritis affects lungs, raises risk of interstitial lung disease

Rheumatoid arthritis affects lungs, raises risk of interstitial lung diseaseRheumatoid arthritis affects the lungs and raises the risk of interstitial lung disease. Rheumatoid arthritis is an autoimmune type of arthritis, and although it primarily affects the joints, it can affect other body parts and organs, too.

According to researchers, respiratory conditions are the second leading cause of death among rheumatoid arthritis patients. Some are a result of rheumatoid arthritis directly, while others are a byproduct of rheumatoid arthritis treatments.


Interstitial lung disease (ILD) is a pulmonary condition characterized by the progressive and irreversible scarring of lung tissue. ILD is the most serious and common lung disease among rheumatoid arthritis patients. Symptoms may take years to appear, but once they do appear the risk of mortality is already quite high. Symptoms of ILD include breathlessness, dry cough, wheezing, chest pain, and the clubbing of fingernails.

A 2008 study found that rheumatoid arthritis patients who smoke are at a higher risk of asymptomatic ILD, compared to those who do not. Treatment of rheumatoid arthritis with methotrexate is also a risk factor for ILD.

ILD isn’t the only lung disease which rheumatoid arthritis is associated with. In fact, it is also linked to pulmonary fibrosis, nodules, pleurisy, and effusions.

Rheumatoid arthritis drugs affecting your lungs

As mentioned, treatment for rheumatoid arthritis can increase the risk of lung diseases, too. Biologic agents have been found to worsen outcomes in patients with already diagnosed ILD, but on the other hand, some may improve outcomes. Specifically, the anti-TNF (anti-tumor necrosis factor) drugs, such as etanercept, infliximab, and adalimumab, have all been reported to worsen ILD in some cases, and many doctors are wary of using these agents in patients who are already breathless as a result of this. On the other hand, anti-B cell drug rituximab is associated with stabilization and even improvement in some patients with ILD.


Other drugs that may increase the risk of lung disease in rheumatoid arthritis include steroids and azathioprine.

Rheumatoid lung disease treatment and prevention

Treating lung disease in rheumatoid arthritis is commonly done with glucocorticoid treatment. In cases where ILD is resistant to glucocorticoid treatment, doctors may prescribe cyclophosphamide, cyclosporine, or azathioprine, though research is limited on their effectiveness.

Some prevention tips against lung disease in rheumatoid arthritis include smoking cessation and regular checkups, as ILD may progress for many years without symptoms and when symptoms appear it may be too late. Regular lung checkups can help spot any issues early on so treatment can begin right away.

Author Bio

Mohan Garikiparithi got his degree in medicine from Osmania University (University of Health Sciences). He practiced clinical medicine for over a decade before he shifted his focus to the field of health communications. During his active practice he served as the head of the Dept. of Microbiology in a diagnostic centre in India. On a three-year communications program in Germany, Mohan developed a keen interest in German Medicine (Homoeopathy), and other alternative systems of medicine. He now advocates treating different medical conditions without the use of traditional drugs. An ardent squash player, Mohan believes in the importance of fitness and wellness.



Related Reading:

Rheumatoid arthritis on its own does not raise cardiovascular complications or death risk after surgery: Study

Rheumatoid arthritis can cause hearing loss due to multiple factors, new study